OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Gastroenterology & Hepatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the	173
Management of disease-related abdominal abscesses in Crohn’s disease	78
Onset of pouchitis after colectomy for ulcerative colitis: reducing the risk	75
Determining the value of endoscopic retrograde cholangiopancreatography in the management of patients with acute pancreatitis and related complications	59
Protective and therapeutic potential of melatonin against intestinal diseases: updated review of current data based on molecular mechanisms	46
The use of personal protective equipment in endoscopy: what should the endoscopist wear during a pandemic?	44
The evolution of clinical outcomes in metastatic pancreatic adenocarcinoma: a 10-year experience at a tertiary referral center	30
Managing pain in irritable bowel syndrome: current perspectives and best practice	28
Advances in understanding of biliary atresia pathogenesis and progression – a riddle wrapped in a mystery inside an enigma	25
Antireflux surgery – choosing the right candidate	25
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients	25
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions	21
Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on long-term survival	21
Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review	20
Towards a better diagnosis of gastro esophageal reflux disease	20
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art	18
Hemostatic powders and gels in gastrointestinal endoscopy: current perspective and future recommendations	17
Beta-adrenergic blockade in cirrhosis – harmful or helpful?	16
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis	16
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?	15
UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease	14
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study	14
Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications	14
When to refer patients for liver elastography	14
Detection methods of synchronous colorectal lesions in proximal colon for patients with obstructive colorectal cancer: a literature review	14

Paraneoplastic syndromes in hepatocellular carcinoma: a review	14
Small bowel transplant – novel indications and recent progress	14
Screening for pancreatic cancer has the potential to save lives, but is it practical?	13
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors	13
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece	13
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?	13
Pneumatic dilation for the treatment of persistent post-laparoscopic fundoplication dysphagia: long-term efficacy and safety	13
Intra-arterial locoregional therapies for intrahepatic cholangiocarcinoma	12
Filgotinib for moderately to severely active ulcerative colitis	12
Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC)	12
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis	12
Clinical efficacy and safety of robot assisted surgery for choledochal cysts excisions: a systematic review and meta-analysis	12
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury	12
Highlighting novel targets in immunotherapy for liver cancer	11
Hepatitis B flare: the good, the bad and the ugly	11
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases	11
Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment	10
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients	10
Cross-talk between immune system and microbiota in COVID-19	10
Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients	10
The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review	10
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis	10
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective	10
Update of gut gas metabolism in ulcerative colitis	9
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making	9
Dual energy computed tomography in Crohn’s disease: a targeted review	9
A practical guide to dilating inflammatory bowel disease strictures	9
Endoscopic drainage versus percutaneous drainage for the management of infected walled-off necrosis: a comparative analysis	9
The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)	9
Capsule endoscopy - a non-invasive modality to investigate the GI tract: out with the old and in with the new?	9
The clinical significance of serum HbA1c to diagnose diabetes mellitus during acute pancreatitis	9
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?	9
Roles of nuclear receptors in hepatic stellate cells	9
Nonachalasic esophageal motor disorders, from diagnosis to therapy	9
Combining therapeutic agents to target the immune systems of hepatitis B patients: what do we need to consider?	9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview	9
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation	9
Gallbladder carcinosarcoma: current perspectives and new development	9
Sleeve gastrectomy with transit bipartition: a review of the literature	9
A narrative review on the diagnosis and management of constipation in infants	9
The role of fibroblast growth factor 19 in the pathogenesis of nonalcoholic fatty liver disease	9
A true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication	8
Diagnostic yield of endoscopic ultrasound-guided liver biopsy in comparison to percutaneous liver biopsy: a systematic review and meta-analysis	8
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir	8
Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease	8
Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication	8
NAFLD and renal function in children: is there a genetic link?	8
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis	8
MASLD: predictive value for liver-related events and extra-hepatic complications	8
Reconstruction of hepatic venous outflow and management of its complications using ex vivo liver resection and autotransplantation: a single-center experience	8

Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy	8
Colonic diverticular disease revisited	8
Serological testing for celiac disease in children	7
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?	7
What is the management of resected cholangiocarcinoma in terms of intra- and postoperative status of tumor margins and lymph nodes? A current view	7
Same versus separate sessions of endoscopic ultrasound-guided fine-needle biopsy and endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction: a propensity score-matched	7
AKI in ACLF: navigating the complex therapeutic puzzle	7
The conundrum in endoscopic management of duodenal polyps: a tertiary cancer center experience	7
Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms	7
Extraintestinal complications of celiac disease: treatment considerations	7
Comprehensive management of gastrointestinal fistulas in necrotizing pancreatitis: a review of diagnostic and therapeutic approaches	7
Application and prospect of artificial intelligence in digestive endoscopy	7
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children	7
Recent advances in treating constipation in children	6
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study	6
Achalasia, from diagnosis to treatment	6
Therapeutics for Clostridioides difficile infection: molecules and microbes	6
Endoscopic sleeve gastroplasty for metabolic dysfunction-associated steatotic liver disease	6
Cirrhosis and non-hepatic surgery in 2023 – a precision medicine approach	6
Hepatobiliary disease after bone marrow transplant	6
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY	6
Risankizumab to treat moderately to severely active Crohn’s disease in adults: an evaluation of trials and data	6
The role of microRNAs in the different phases of liver regeneration	6
Cold resection for colorectal polyps: where we are and where we are going?	6
Irritable bowel syndrome – controversies in diagnosis and management	6
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?	6
PSC associated inflammatory bowel disease: a distinct entity	6
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)	6
Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis	6